Texas § 32.03115 REIMBURSEMENT FOR MEDICATION-ASSISTED TREATMENT FOR OPIOID OR SUBSTANCE USE DISORDER.

Texas Statutes

§ 32.03115 — REIMBURSEMENT FOR MEDICATION-ASSISTED TREATMENT FOR OPIOID OR SUBSTANCE USE DISORDER.

Texas § 32.03115

Code HRHuman Resources Code

This text of Texas § 32.03115 (REIMBURSEMENT FOR MEDICATION-ASSISTED TREATMENT FOR OPIOID OR SUBSTANCE USE DISORDER.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Human Resources Code Code Ann. § 32.03115 (2026).

Text

Sec. 32.03115. REIMBURSEMENT FOR MEDICATION-ASSISTED TREATMENT FOR OPIOID OR SUBSTANCE USE DISORDER.

(a)In this section, "medication-assisted opioid or substance use disorder treatment" means the use of methadone, buprenorphine, oral buprenorphine/naloxone, or naltrexone to treat opioid or substance use disorder.

(b)Notwithstanding Subchapters E and F, Chapter 549 , Government Code, or any other law and subject to Subsections (c) and (d), the commission shall provide medical assistance reimbursement for medication-assisted opioid or substance use disorder treatment without requiring a recipient of medical assistance or health care provider to obtain prior authorization or precertification for the treatment, except as needed to minimize the opportunity for fraud, waste, or abuse.

(c)The

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 32.03115. REIMBURSEMENT FOR MEDICATION-ASSISTED TREATMENT FOR OPIOID OR SUBSTANCE USE DISORDER. (a) In this section, "medication-assisted opioid or substance use disorder treatment" means the use of methadone, buprenorphine, oral buprenorphine/naloxone, or naltrexone to treat opioid or substance use disorder.
(b) Notwithstanding Subchapters E and F, Chapter 549 , Government Code, or any other law and subject to Subsections (c) and (d), the commission shall provide medical assistance reimbursement for medication-assisted opioid or substance use disorder treatment without requiring a recipient of medical assistance or health care provider to obtain prior authorization or precertification for the treatment, except as needed to minimize the opportunity for fraud, waste, or abuse.
(c) The duty to provide medical assistance reimbursement for medication-assisted opioid or substance use disorder treatment under Subsection (b) does not apply with respect to:
(1) a prescription for methadone;
(2) a recipient for whom medication-assisted opioid or substance use disorder treatment is determined to be medically contraindicated by the recipient's physician; or
(3) a recipient who is subject to an age-related restriction applicable to medication-assisted opioid or substance use disorder treatment.
(d) The commission may provide medical assistance reimbursement for medication-assisted opioid or substance use disorder treatment only if the treatment is prescribed to a recipient of medical assistance by a licensed health care provider who is authorized to prescribe methadone, buprenorphine, oral buprenorphine/naloxone, or naltrexone.
(e) Repealed by Acts 2023, 88th Leg., R.S., Ch. 816 (H.B. 1357 ), Sec. 1, eff. June 13, 2023.

Legislative History

Added by Acts 2019, 86th Leg., R.S., Ch. 640 (S.B. 1564 ), Sec. 2, eff. June 10, 2019. Added by Acts 2019, 86th Leg., R.S., Ch. 1105 (H.B. 2174 ), Sec. 13, eff. September 1, 2019. Added by Acts 2019, 86th Leg., R.S., Ch. 1167 (H.B. 3285 ), Sec. 9, eff. September 1, 2019. Amended by: Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611 ), Sec. 2.82, eff. April 1, 2025. Acts 2023, 88th Leg., R.S., Ch. 816 (H.B. 1357 ), Sec. 1, eff. June 13, 2023. Acts 2025, 89th Leg., R.S., Ch. 204 (H.B. 1620 ), Sec. 10.001, eff. September 1, 2025.